Veronica Ueckermann
University of Pretoria(ZA)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, COVID-19 and healthcare impacts, Long-Term Effects of COVID-19, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma(2021)1,264 cited
- → T cell responses to SARS-CoV-2 spike cross-recognize Omicron(2022)615 cited
- → Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa(2021)436 cited
- → Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)(2021)143 cited
- → SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals(2022)122 cited
- → SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity(2022)85 cited
- → SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron(2021)72 cited
- → SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies(2021)39 cited
- → Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern(2022)37 cited